<p>They discuss recent advances, what&#39;s ahead, Cigall&#39;s work in epigenetics, and how a new hospital will be purpose built for patients with the best new technologies in clinical research.</p>

Oxford, UK based OMass Therapeutics announced a $310M series C today, advancing its small molecule platform, including the lead MC2 (melanocortin-2) receptor antagonist that is in phase 1

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

Anchor (from Spotify)

BiotechTV - News

Eli Lilly Chairman & CEO David Ricks discusses GLP-1's, Alzheimer's, business development and more

At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research